Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2552 stock hub

HKG/2552 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2552is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2552

In the news

Latest news · HKG/2552

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E2.7

P25 10.7P50 17.9P75 38.5

ROE254

P25 -14.7P50 2P75 9.4

ROIC-12.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2552 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

CNY

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	328
Employees Change	160%
Employees Change Percent	95.24
Enterprise value	HKD 2.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG4644K1022
Last refreshed	2026-05-10
Market cap	HKD 3.3B
Price	HKD 3.35
Price currency	HKD
Rev Per Employee	1,672,384.17x
Sector	Healthcare
Sic	2836
Symbol	hkg/2552
Website	https://www.huamedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	36.88%
EV Earnings	2x
EV/FCF	-37.01x
EV/Sales	4.48x
FCF yield	-1.99%
P/B ratio	2.98x
P/E ratio	2.74x
P/S ratio	6.09x
PE Ratio3 Y	3.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-29.39%
EBITDA Margin	-26.74%
Gross margin	56.87%
Gross Profit	HKD 312M
Gross Profit Growth	43.93%
Gross Profit Growth Q	111.19%
Gross Profit Growth3 Y	89.67%
Gross Profit Growth5 Y	40.21%
Net Income	HKD 1.2B
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	224.44%
Profit Margin	224.44%
Profit Per Employee	HKD 3.8M
Profitable Years	1
ROA	-6.04
Roa5y	-14.07
ROCE	-11.5
ROE	254
ROIC	-12.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	60.34%
Cagr3y	4.21%
Cagr5y	-6.47%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	92.63x
Revenue Growth Q	79.8x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	65.4x
Revenue Growth5 Y	41.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.33
Assets	HKD 1.6B
Cash	HKD 1.2B
Current Assets	HKD 1.5B
Current Liabilities	HKD 242.1M
Debt	HKD 335.7M
Debt Equity	HKD 0.3
Debt FCF	HKD -5.05
Equity	HKD 1.1B
Interest Coverage	-17.79
Liabilities	HKD 515.5M
Long Term Assets	HKD 142.6M
Long Term Liabilities	HKD 273.4M
Net Cash	HKD 879.8M
Net Cash By Market Cap	HKD 26.35
Net Cash Growth	-5.83%
Net Debt Equity	HKD -0.79
Tangible Book Value	HKD 1.1B
Tangible Book Value Per Share	HKD 1.1
WACC	8.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.17
Inventory Turnover	1.71
Net Working Capital	HKD 47.3M
Quick ratio	5.57
Working Capital	HKD 1.2B
Working Capital Turnover	HKD 0.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	60.29%
200-day SMA	3.47
3Y total return	13.18%
50-day SMA	3.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-28.42%
All Time High	9
All Time High Change	-62.78%
All Time High Date	2020-08-17
All Time Low	1.03
All Time Low Change	225.24%
All Time Low Date	2024-09-03
ATR	0.15
Beta	0.84
Beta1y	1.62
Beta2y	1.31
Ch YTD	8.77
High	3.48
High52	4.95
High52 Date	2025-10-08
High52ch	-32.32%
Low	3.34
Low52	1.87
Low52 Date	2025-05-13
Low52ch	79.14%
Ma50ch	0.24%
Price vs 200-day SMA	-3.46%
RSI	45.58
RSI Monthly	56.96
RSI Weekly	51.15
Sharpe ratio	0.9x
Sortino ratio	1.51
Total Return	-2.33%
Tr YTD	8.77
Tr1m	-8.22%
Tr1w	-0.59%
Tr3m	17.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -161.2M
Operating margin	-29.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	661,310,457%
Net Borrowing	-8,275,132.1
Shares Insiders	5.5%
Shares Institutions	1.52%
Shares Out	996,519,632
Shares Qo Q	2.44%
Shares Yo Y	2.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -80M
Average Volume	2,676,024.5x
Bv Per Share	1.12
CAPEX	HKD -8.4M
Ch1m	-8.22
Ch1w	-0.59
Ch1y	60.29
Ch3m	17.13
Ch3y	13.18
Ch5y	-28.42
Ch6m	6.01
Change	-0.59%
Change From Open	-0.59
Close	3.37
Days Gap	0
Depreciation Amortization	15,069,354.1
Dollar Volume	9,351,525
Earnings Date	2026-03-26
EBIT	HKD -161.2M
EBITDA	HKD -146.7M
EPS	HKD 1.22
F Score	3
FCF	HKD -66.4M
FCF EV Yield	-2.7x
FCF Per Share	HKD -0.07
Financing CF	10,126,573
Fiscal Year End	December
Founded	2,011
Graham Number	5.56368
Graham Upside	66.08
Investing CF	-727,778
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	3.37
Ma150ch	-0.53%
Ma20	3.53
Ma20ch	-5.05%
Net CF	-52,819,538
Open	3.37
Position In Range	7.14
Ppne	126,755,999.8
Price Date	2026-05-08
Ptbv Ratio	3.05
Relative Volume	1.05x
Revenue	548,542,007x
SBC By Revenue	2.47x
Share Based Comp	13,560,706
Tr6m	6.01%
Volume	2,791,500
Z Score	-0.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2552 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2552 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2552?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.5%

Share of float held by funds and institutions

Insider ownership

+5.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.3%

Negative means the company is buying back shares.

Technical

HKG/2552 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

0.84

Moves roughly with the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2552

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2552 stock rating?

hkg/2552 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2552 analysis?

The full report lives at /stocks/hkg/2552/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2552?

The latest report frames hkg/2552 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2552 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.